+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
New

Global Exosome Diagnostics and Therapeutics Market 2024-2028

  • PDF Icon

    Report

  • 164 Pages
  • January 2024
  • Region: Global
  • TechNavio
  • ID: 5515011
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The exosome diagnostics and therapeutics market is forecasted to grow by USD 687.63 mn during 2023-2028, accelerating at a CAGR of 23.36% during the forecast period. The report on the exosome diagnostics and therapeutics market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by raising research on exosome therapeutics, increasing demand for effective drugs for chronic diseases, and growing focus on early detection of cancer.

The exosome diagnostics and therapeutics market is segmented as below:

By Application

  • Diagnostic
  • Therapeutic

By End-user

  • Research and academic institutes
  • Pharmaceutical and biotechnology companies
  • Commercial

By Geographical Landscape

  • North America
  • Europe
  • Asia
  • Rest of World (ROW)
This study identifies the advanced technology in exosome collection as one of the prime reasons driving the exosome diagnostics and therapeutics market growth during the next few years. Also, potential of exosomes in personalized medicine and rising focus on regenerative medicine will lead to sizable demand in the market.

The report on the exosome diagnostics and therapeutics market covers the following areas:

  • Exosome diagnostics and therapeutics market sizing
  • Exosome diagnostics and therapeutics market forecast
  • Exosome diagnostics and therapeutics market industry analysis
The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading exosome diagnostics and therapeutics market vendors that include Aethlon Medical Inc., Bio Techne Corp., BioCat GmbH, BioVision Inc., Capricor Therapeutics Inc., Cell Guidance Systems Ltd., Clara Biotech Inc., Evox Therapeutics Ltd., Hologic Inc., JSR Life Sciences LLC, Lonza Group Ltd., Merck KGaA, Miltenyi Biotec B.V. and Co. KG, Nanosomix Inc., NX PharmaGen Inc., QIAGEN NV, ReNeuron Group plc, Sarepta Therapeutics Inc, System Biosciences LLC, and Thermo Fisher Scientific Inc.. Also, the exosome diagnostics and therapeutics market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

Table of Contents

1 Executive Summary
1.1 Market overview
Exhibit 01: Executive Summary - Chart on Market Overview
Exhibit 02: Executive Summary - Data Table on Market Overview
Exhibit 03: Executive Summary - Chart on Global Market Characteristics
Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
Exhibit 05: Executive Summary - Chart on Market Segmentation by Application
Exhibit 06: Executive Summary - Chart on Market Segmentation by End-user
Exhibit 07: Executive Summary - Chart on Incremental Growth
Exhibit 08: Executive Summary - Data Table on Incremental Growth
Exhibit 09: Executive Summary - Chart on Vendor Market Positioning
2 Market Landscape
2.1 Market ecosystem
Exhibit 10: Parent market
Exhibit 11: Market Characteristics
3 Market Sizing
3.1 Market definition
Exhibit 12: Offerings of vendors included in the market definition
3.2 Market segment analysis
Exhibit 13: Market segments
3.3 Market size 2023
3.4 Market outlook: Forecast for 2023-2028
Exhibit 14: Chart on Global - Market size and forecast 2023-2028 ($ million)
Exhibit 15: Data Table on Global - Market size and forecast 2023-2028 ($ million)
Exhibit 16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
Exhibit 17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
4 Historic Market Size
4.1 Global exosome diagnostics and therapeutics market 2018 - 2022
Exhibit 18: Historic Market Size - Data Table on global exosome diagnostics and therapeutics market 2018 - 2022 ($ million)
4.2 Application Segment Analysis 2018 - 2022
Exhibit 19: Historic Market Size - Application Segment 2018 - 2022 ($ million)
4.3 End-user Segment Analysis 2018 - 2022
Exhibit 20: Historic Market Size - End-user Segment 2018 - 2022 ($ million)
4.4 Geography Segment Analysis 2018 - 2022
Exhibit 21: Historic Market Size - Geography Segment 2018 - 2022 ($ million)
4.5 Country Segment Analysis 2018 - 2022
Exhibit 22: Historic Market Size - Country Segment 2018 - 2022 ($ million)
5 Five Forces Analysis
5.1 Five forces summary
Exhibit 23: Five forces analysis - Comparison between 2023 and 2028
5.2 Bargaining power of buyers
Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2023 and 2028
5.3 Bargaining power of suppliers
Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
5.4 Threat of new entrants
Exhibit 26: Threat of new entrants - Impact of key factors in 2023 and 2028
5.5 Threat of substitutes
Exhibit 27: Threat of substitutes - Impact of key factors in 2023 and 2028
5.6 Threat of rivalry
Exhibit 28: Threat of rivalry - Impact of key factors in 2023 and 2028
5.7 Market condition
Exhibit 29: Chart on Market condition - Five forces 2023 and 2028
6 Market Segmentation by Application
6.1 Market segments
Exhibit 30: Chart on Application - Market share 2023-2028 (%)
Exhibit 31: Data Table on Application - Market share 2023-2028 (%)
6.2 Comparison by Application
Exhibit 32: Chart on Comparison by Application
Exhibit 33: Data Table on Comparison by Application
6.3 Diagnostic - Market size and forecast 2023-2028
Exhibit 34: Chart on Diagnostic - Market size and forecast 2023-2028 ($ million)
Exhibit 35: Data Table on Diagnostic - Market size and forecast 2023-2028 ($ million)
Exhibit 36: Chart on Diagnostic - Year-over-year growth 2023-2028 (%)
Exhibit 37: Data Table on Diagnostic - Year-over-year growth 2023-2028 (%)
6.4 Therapeutic - Market size and forecast 2023-2028
Exhibit 38: Chart on Therapeutic - Market size and forecast 2023-2028 ($ million)
Exhibit 39: Data Table on Therapeutic - Market size and forecast 2023-2028 ($ million)
Exhibit 40: Chart on Therapeutic - Year-over-year growth 2023-2028 (%)
Exhibit 41: Data Table on Therapeutic - Year-over-year growth 2023-2028 (%)
6.5 Market opportunity by Application
Exhibit 42: Market opportunity by Application ($ million)
Exhibit 43: Data Table on Market opportunity by Application ($ million)
7 Market Segmentation by End-user
7.1 Market segments
Exhibit 44: Chart on End-user - Market share 2023-2028 (%)
Exhibit 45: Data Table on End-user - Market share 2023-2028 (%)
7.2 Comparison by End-user
Exhibit 46: Chart on Comparison by End-user
Exhibit 47: Data Table on Comparison by End-user
7.3 Research and academic institutes - Market size and forecast 2023-2028
Exhibit 48: Chart on Research and academic institutes - Market size and forecast 2023-2028 ($ million)
Exhibit 49: Data Table on Research and academic institutes - Market size and forecast 2023-2028 ($ million)
Exhibit 50: Chart on Research and academic institutes - Year-over-year growth 2023-2028 (%)
Exhibit 51: Data Table on Research and academic institutes - Year-over-year growth 2023-2028 (%)
7.4 Pharmaceutical and biotechnology companies - Market size and forecast 2023-2028
Exhibit 52: Chart on Pharmaceutical and biotechnology companies - Market size and forecast 2023-2028 ($ million)
Exhibit 53: Data Table on Pharmaceutical and biotechnology companies - Market size and forecast 2023-2028 ($ million)
Exhibit 54: Chart on Pharmaceutical and biotechnology companies - Year-over-year growth 2023-2028 (%)
Exhibit 55: Data Table on Pharmaceutical and biotechnology companies - Year-over-year growth 2023-2028 (%)
7.5 Commercial - Market size and forecast 2023-2028
Exhibit 56: Chart on Commercial - Market size and forecast 2023-2028 ($ million)
Exhibit 57: Data Table on Commercial - Market size and forecast 2023-2028 ($ million)
Exhibit 58: Chart on Commercial - Year-over-year growth 2023-2028 (%)
Exhibit 59: Data Table on Commercial - Year-over-year growth 2023-2028 (%)
7.6 Market opportunity by End-user
Exhibit 60: Market opportunity by End-user ($ million)
Exhibit 61: Data Table on Market opportunity by End-user ($ million)
8 Customer Landscape
8.1 Customer landscape overview
Exhibit 62: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
9 Geographic Landscape
9.1 Geographic segmentation
Exhibit 63: Chart on Market share By Geographical Landscape 2023-2028 (%)
Exhibit 64: Data Table on Market share By Geographical Landscape 2023-2028 (%)
9.2 Geographic comparison
Exhibit 65: Chart on Geographic comparison
Exhibit 66: Data Table on Geographic comparison
9.3 North America - Market size and forecast 2023-2028
Exhibit 67: Chart on North America - Market size and forecast 2023-2028 ($ million)
Exhibit 68: Data Table on North America - Market size and forecast 2023-2028 ($ million)
Exhibit 69: Chart on North America - Year-over-year growth 2023-2028 (%)
Exhibit 70: Data Table on North America - Year-over-year growth 2023-2028 (%)
9.4 Europe - Market size and forecast 2023-2028
Exhibit 71: Chart on Europe - Market size and forecast 2023-2028 ($ million)
Exhibit 72: Data Table on Europe - Market size and forecast 2023-2028 ($ million)
Exhibit 73: Chart on Europe - Year-over-year growth 2023-2028 (%)
Exhibit 74: Data Table on Europe - Year-over-year growth 2023-2028 (%)
9.5 Asia - Market size and forecast 2023-2028
Exhibit 75: Chart on Asia - Market size and forecast 2023-2028 ($ million)
Exhibit 76: Data Table on Asia - Market size and forecast 2023-2028 ($ million)
Exhibit 77: Chart on Asia - Year-over-year growth 2023-2028 (%)
Exhibit 78: Data Table on Asia - Year-over-year growth 2023-2028 (%)
9.6 Rest of World (ROW) - Market size and forecast 2023-2028
Exhibit 79: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Exhibit 80: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Exhibit 81: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibit 82: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
9.7 US - Market size and forecast 2023-2028
Exhibit 83: Chart on US - Market size and forecast 2023-2028 ($ million)
Exhibit 84: Data Table on US - Market size and forecast 2023-2028 ($ million)
Exhibit 85: Chart on US - Year-over-year growth 2023-2028 (%)
Exhibit 86: Data Table on US - Year-over-year growth 2023-2028 (%)
9.8 Germany - Market size and forecast 2023-2028
Exhibit 87: Chart on Germany - Market size and forecast 2023-2028 ($ million)
Exhibit 88: Data Table on Germany - Market size and forecast 2023-2028 ($ million)
Exhibit 89: Chart on Germany - Year-over-year growth 2023-2028 (%)
Exhibit 90: Data Table on Germany - Year-over-year growth 2023-2028 (%)
9.9 UK - Market size and forecast 2023-2028
Exhibit 91: Chart on UK - Market size and forecast 2023-2028 ($ million)
Exhibit 92: Data Table on UK - Market size and forecast 2023-2028 ($ million)
Exhibit 93: Chart on UK - Year-over-year growth 2023-2028 (%)
Exhibit 94: Data Table on UK - Year-over-year growth 2023-2028 (%)
9.10 China - Market size and forecast 2023-2028
Exhibit 95: Chart on China - Market size and forecast 2023-2028 ($ million)
Exhibit 96: Data Table on China - Market size and forecast 2023-2028 ($ million)
Exhibit 97: Chart on China - Year-over-year growth 2023-2028 (%)
Exhibit 98: Data Table on China - Year-over-year growth 2023-2028 (%)
9.11 Japan - Market size and forecast 2023-2028
Exhibit 99: Chart on Japan - Market size and forecast 2023-2028 ($ million)
Exhibit 100: Data Table on Japan - Market size and forecast 2023-2028 ($ million)
Exhibit 101: Chart on Japan - Year-over-year growth 2023-2028 (%)
Exhibit 102: Data Table on Japan - Year-over-year growth 2023-2028 (%)
9.12 Market opportunity By Geographical Landscape
Exhibit 103: Market opportunity By Geographical Landscape ($ million)
Exhibit 104: Data Tables on Market opportunity By Geographical Landscape ($ million)
10 Drivers, Challenges, and Trends
10.1 Market drivers
10.2 Market challenges
10.3 Impact of drivers and challenges
Exhibit 105: Impact of drivers and challenges in 2023 and 2028
10.4 Market trends
11 Vendor Landscape
11.1 Overview
11.2 Vendor landscape
Exhibit 106: Overview on Criticality of inputs and Factors of differentiation
11.3 Landscape disruption
Exhibit 107: Overview on factors of disruption
11.4 Industry risks
Exhibit 108: Impact of key risks on business
12 Vendor Analysis
12.1 Vendors covered
Exhibit 109: Vendors covered
12.2 Market positioning of vendors
Exhibit 110: Matrix on vendor position and classification
12.3 Aethlon Medical Inc.
Exhibit 111: Aethlon Medical Inc. - Overview
Exhibit 112: Aethlon Medical Inc. - Business segments
Exhibit 113: Aethlon Medical Inc. - Key offerings
Exhibit 114: Aethlon Medical Inc. - Segment focus
12.4 Bio Techne Corp.
Exhibit 115: Bio Techne Corp. - Overview
Exhibit 116: Bio Techne Corp. - Business segments
Exhibit 117: Bio Techne Corp. - Key offerings
Exhibit 118: Bio Techne Corp. - Segment focus
12.5 Capricor Therapeutics Inc.
Exhibit 119: Capricor Therapeutics Inc. - Overview
Exhibit 120: Capricor Therapeutics Inc. - Product / Service
Exhibit 121: Capricor Therapeutics Inc. - Key offerings
12.6 Evox Therapeutics Ltd.
Exhibit 122: Evox Therapeutics Ltd. - Overview
Exhibit 123: Evox Therapeutics Ltd. - Product / Service
Exhibit 124: Evox Therapeutics Ltd. - Key offerings
12.7 Hologic Inc.
Exhibit 125: Hologic Inc. - Overview
Exhibit 126: Hologic Inc. - Business segments
Exhibit 127: Hologic Inc. - Key news
Exhibit 128: Hologic Inc. - Key offerings
Exhibit 129: Hologic Inc. - Segment focus
12.8 JSR Life Sciences LLC
Exhibit 130: JSR Life Sciences LLC - Overview
Exhibit 131: JSR Life Sciences LLC - Product / Service
Exhibit 132: JSR Life Sciences LLC - Key offerings
12.9 Lonza Group Ltd.
Exhibit 133: Lonza Group Ltd. - Overview
Exhibit 134: Lonza Group Ltd. - Business segments
Exhibit 135: Lonza Group Ltd. - Key news
Exhibit 136: Lonza Group Ltd. - Key offerings
Exhibit 137: Lonza Group Ltd. - Segment focus
12.10 Merck KGaA
Exhibit 138: Merck KGaA - Overview
Exhibit 139: Merck KGaA - Business segments
Exhibit 140: Merck KGaA - Key news
Exhibit 141: Merck KGaA - Key offerings
Exhibit 142: Merck KGaA - Segment focus
12.11 Miltenyi Biotec B.V. and Co. KG
Exhibit 143: Miltenyi Biotec B.V. and Co. KG - Overview
Exhibit 144: Miltenyi Biotec B.V. and Co. KG - Product / Service
Exhibit 145: Miltenyi Biotec B.V. and Co. KG - Key offerings
12.12 Nanosomix Inc.
Exhibit 146: Nanosomix Inc. - Overview
Exhibit 147: Nanosomix Inc. - Product / Service
Exhibit 148: Nanosomix Inc. - Key offerings
12.13 NX PharmaGen Inc.
Exhibit 149: NX PharmaGen Inc. - Overview
Exhibit 150: NX PharmaGen Inc. - Product / Service
Exhibit 151: NX PharmaGen Inc. - Key offerings
12.14 QIAGEN NV
Exhibit 152: QIAGEN NV - Overview
Exhibit 153: QIAGEN NV - Product / Service
Exhibit 154: QIAGEN NV - Key news
Exhibit 155: QIAGEN NV - Key offerings
12.15 Sarepta Therapeutics Inc
Exhibit 156: Sarepta Therapeutics Inc - Overview
Exhibit 157: Sarepta Therapeutics Inc - Product / Service
Exhibit 158: Sarepta Therapeutics Inc - Key offerings
12.16 System Biosciences LLC
Exhibit 159: System Biosciences LLC - Overview
Exhibit 160: System Biosciences LLC - Product / Service
Exhibit 161: System Biosciences LLC - Key offerings
12.17 Thermo Fisher Scientific Inc.
Exhibit 162: Thermo Fisher Scientific Inc. - Overview
Exhibit 163: Thermo Fisher Scientific Inc. - Business segments
Exhibit 164: Thermo Fisher Scientific Inc. - Key news
Exhibit 165: Thermo Fisher Scientific Inc. - Key offerings
Exhibit 166: Thermo Fisher Scientific Inc. - Segment focus
13 Appendix
13.1 Scope of the report
13.2 Inclusions and exclusions checklist
Exhibit 167: Inclusions checklist
Exhibit 168: Exclusions checklist
13.3 Currency conversion rates for US$
Exhibit 169: Currency conversion rates for US$
13.4 Research methodology
Exhibit 170: Research methodology
Exhibit 171: Validation techniques employed for market sizing
Exhibit 172: Information sources
13.5 List of abbreviations
Exhibit 173: List of abbreviations
List of Exhibits
Exhibits 1: Executive Summary - Chart on Market Overview
Exhibits 2: Executive Summary - Data Table on Market Overview
Exhibits 3: Executive Summary - Chart on Global Market Characteristics
Exhibits 4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits 5: Executive Summary - Chart on Market Segmentation by Application
Exhibits 6: Executive Summary - Chart on Market Segmentation by End-user
Exhibits 7: Executive Summary - Chart on Incremental Growth
Exhibits 8: Executive Summary - Data Table on Incremental Growth
Exhibits 9: Executive Summary - Chart on Vendor Market Positioning
Exhibits 10: Parent market
Exhibits 11: Market Characteristics
Exhibits 12: Offerings of vendors included in the market definition
Exhibits 13: Market segments
Exhibits 14: Chart on Global - Market size and forecast 2023-2028 ($ million)
Exhibits 15: Data Table on Global - Market size and forecast 2023-2028 ($ million)
Exhibits 16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits 17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits 18: Historic Market Size - Data Table on global exosome diagnostics and therapeutics market 2018 - 2022 ($ million)
Exhibits 19: Historic Market Size - Application Segment 2018 - 2022 ($ million)
Exhibits 20: Historic Market Size - End-user Segment 2018 - 2022 ($ million)
Exhibits 21: Historic Market Size - Geography Segment 2018 - 2022 ($ million)
Exhibits 22: Historic Market Size - Country Segment 2018 - 2022 ($ million)
Exhibits 23: Five forces analysis - Comparison between 2023 and 2028
Exhibits 24: Chart on Bargaining power of buyers - Impact of key factors 2023 and 2028
Exhibits 25: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
Exhibits 26: Threat of new entrants - Impact of key factors in 2023 and 2028
Exhibits 27: Threat of substitutes - Impact of key factors in 2023 and 2028
Exhibits 28: Threat of rivalry - Impact of key factors in 2023 and 2028
Exhibits 29: Chart on Market condition - Five forces 2023 and 2028
Exhibits 30: Chart on Application - Market share 2023-2028 (%)
Exhibits 31: Data Table on Application - Market share 2023-2028 (%)
Exhibits 32: Chart on Comparison by Application
Exhibits 33: Data Table on Comparison by Application
Exhibits 34: Chart on Diagnostic - Market size and forecast 2023-2028 ($ million)
Exhibits 35: Data Table on Diagnostic - Market size and forecast 2023-2028 ($ million)
Exhibits 36: Chart on Diagnostic - Year-over-year growth 2023-2028 (%)
Exhibits 37: Data Table on Diagnostic - Year-over-year growth 2023-2028 (%)
Exhibits 38: Chart on Therapeutic - Market size and forecast 2023-2028 ($ million)
Exhibits 39: Data Table on Therapeutic - Market size and forecast 2023-2028 ($ million)
Exhibits 40: Chart on Therapeutic - Year-over-year growth 2023-2028 (%)
Exhibits 41: Data Table on Therapeutic - Year-over-year growth 2023-2028 (%)
Exhibits 42: Market opportunity by Application ($ million)
Exhibits 43: Data Table on Market opportunity by Application ($ million)
Exhibits 44: Chart on End-user - Market share 2023-2028 (%)
Exhibits 45: Data Table on End-user - Market share 2023-2028 (%)
Exhibits 46: Chart on Comparison by End-user
Exhibits 47: Data Table on Comparison by End-user
Exhibits 48: Chart on Research and academic institutes - Market size and forecast 2023-2028 ($ million)
Exhibits 49: Data Table on Research and academic institutes - Market size and forecast 2023-2028 ($ million)
Exhibits 50: Chart on Research and academic institutes - Year-over-year growth 2023-2028 (%)
Exhibits 51: Data Table on Research and academic institutes - Year-over-year growth 2023-2028 (%)
Exhibits 52: Chart on Pharmaceutical and biotechnology companies - Market size and forecast 2023-2028 ($ million)
Exhibits 53: Data Table on Pharmaceutical and biotechnology companies - Market size and forecast 2023-2028 ($ million)
Exhibits 54: Chart on Pharmaceutical and biotechnology companies - Year-over-year growth 2023-2028 (%)
Exhibits 55: Data Table on Pharmaceutical and biotechnology companies - Year-over-year growth 2023-2028 (%)
Exhibits 56: Chart on Commercial - Market size and forecast 2023-2028 ($ million)
Exhibits 57: Data Table on Commercial - Market size and forecast 2023-2028 ($ million)
Exhibits 58: Chart on Commercial - Year-over-year growth 2023-2028 (%)
Exhibits 59: Data Table on Commercial - Year-over-year growth 2023-2028 (%)
Exhibits 60: Market opportunity by End-user ($ million)
Exhibits 61: Data Table on Market opportunity by End-user ($ million)
Exhibits 62: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits 63: Chart on Market share By Geographical Landscape 2023-2028 (%)
Exhibits 64: Data Table on Market share By Geographical Landscape 2023-2028 (%)
Exhibits 65: Chart on Geographic comparison
Exhibits 66: Data Table on Geographic comparison
Exhibits 67: Chart on North America - Market size and forecast 2023-2028 ($ million)
Exhibits 68: Data Table on North America - Market size and forecast 2023-2028 ($ million)
Exhibits 69: Chart on North America - Year-over-year growth 2023-2028 (%)
Exhibits 70: Data Table on North America - Year-over-year growth 2023-2028 (%)
Exhibits 71: Chart on Europe - Market size and forecast 2023-2028 ($ million)
Exhibits 72: Data Table on Europe - Market size and forecast 2023-2028 ($ million)
Exhibits 73: Chart on Europe - Year-over-year growth 2023-2028 (%)
Exhibits 74: Data Table on Europe - Year-over-year growth 2023-2028 (%)
Exhibits 75: Chart on Asia - Market size and forecast 2023-2028 ($ million)
Exhibits 76: Data Table on Asia - Market size and forecast 2023-2028 ($ million)
Exhibits 77: Chart on Asia - Year-over-year growth 2023-2028 (%)
Exhibits 78: Data Table on Asia - Year-over-year growth 2023-2028 (%)
Exhibits 79: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Exhibits 80: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Exhibits 81: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibits 82: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibits 83: Chart on US - Market size and forecast 2023-2028 ($ million)
Exhibits 84: Data Table on US - Market size and forecast 2023-2028 ($ million)
Exhibits 85: Chart on US - Year-over-year growth 2023-2028 (%)
Exhibits 86: Data Table on US - Year-over-year growth 2023-2028 (%)
Exhibits 87: Chart on Germany - Market size and forecast 2023-2028 ($ million)
Exhibits 88: Data Table on Germany - Market size and forecast 2023-2028 ($ million)
Exhibits 89: Chart on Germany - Year-over-year growth 2023-2028 (%)
Exhibits 90: Data Table on Germany - Year-over-year growth 2023-2028 (%)
Exhibits 91: Chart on UK - Market size and forecast 2023-2028 ($ million)
Exhibits 92: Data Table on UK - Market size and forecast 2023-2028 ($ million)
Exhibits 93: Chart on UK - Year-over-year growth 2023-2028 (%)
Exhibits 94: Data Table on UK - Year-over-year growth 2023-2028 (%)
Exhibits 95: Chart on China - Market size and forecast 2023-2028 ($ million)
Exhibits 96: Data Table on China - Market size and forecast 2023-2028 ($ million)
Exhibits 97: Chart on China - Year-over-year growth 2023-2028 (%)
Exhibits 98: Data Table on China - Year-over-year growth 2023-2028 (%)
Exhibits 99: Chart on Japan - Market size and forecast 2023-2028 ($ million)
Exhibits 100: Data Table on Japan - Market size and forecast 2023-2028 ($ million)
Exhibits 101: Chart on Japan - Year-over-year growth 2023-2028 (%)
Exhibits 102: Data Table on Japan - Year-over-year growth 2023-2028 (%)
Exhibits 103: Market opportunity By Geographical Landscape ($ million)
Exhibits 104: Data Tables on Market opportunity By Geographical Landscape ($ million)
Exhibits 105: Impact of drivers and challenges in 2023 and 2028
Exhibits 106: Overview on Criticality of inputs and Factors of differentiation
Exhibits 107: Overview on factors of disruption
Exhibits 108: Impact of key risks on business
Exhibits 109: Vendors covered
Exhibits 110: Matrix on vendor position and classification
Exhibits 111: Aethlon Medical Inc. - Overview
Exhibits 112: Aethlon Medical Inc. - Business segments
Exhibits 113: Aethlon Medical Inc. - Key offerings
Exhibits 114: Aethlon Medical Inc. - Segment focus
Exhibits 115: Bio Techne Corp. - Overview
Exhibits 116: Bio Techne Corp. - Business segments
Exhibits 117: Bio Techne Corp. - Key offerings
Exhibits 118: Bio Techne Corp. - Segment focus
Exhibits 119: Capricor Therapeutics Inc. - Overview
Exhibits 120: Capricor Therapeutics Inc. - Product / Service
Exhibits 121: Capricor Therapeutics Inc. - Key offerings
Exhibits 122: Evox Therapeutics Ltd. - Overview
Exhibits 123: Evox Therapeutics Ltd. - Product / Service
Exhibits 124: Evox Therapeutics Ltd. - Key offerings
Exhibits 125: Hologic Inc. - Overview
Exhibits 126: Hologic Inc. - Business segments
Exhibits 127: Hologic Inc. - Key news
Exhibits 128: Hologic Inc. - Key offerings
Exhibits 129: Hologic Inc. - Segment focus
Exhibits 130: JSR Life Sciences LLC - Overview
Exhibits 131: JSR Life Sciences LLC - Product / Service
Exhibits 132: JSR Life Sciences LLC - Key offerings
Exhibits 133: Lonza Group Ltd. - Overview
Exhibits 134: Lonza Group Ltd. - Business segments
Exhibits 135: Lonza Group Ltd. - Key news
Exhibits 136: Lonza Group Ltd. - Key offerings
Exhibits 137: Lonza Group Ltd. - Segment focus
Exhibits 138: Merck KGaA - Overview
Exhibits 139: Merck KGaA - Business segments
Exhibits 140: Merck KGaA - Key news
Exhibits 141: Merck KGaA - Key offerings
Exhibits 142: Merck KGaA - Segment focus
Exhibits 143: Miltenyi Biotec B.V. and Co. KG - Overview
Exhibits 144: Miltenyi Biotec B.V. and Co. KG - Product / Service
Exhibits 145: Miltenyi Biotec B.V. and Co. KG - Key offerings
Exhibits 146: Nanosomix Inc. - Overview
Exhibits 147: Nanosomix Inc. - Product / Service
Exhibits 148: Nanosomix Inc. - Key offerings
Exhibits 149: NX PharmaGen Inc. - Overview
Exhibits 150: NX PharmaGen Inc. - Product / Service
Exhibits 151: NX PharmaGen Inc. - Key offerings
Exhibits 152: QIAGEN NV - Overview
Exhibits 153: QIAGEN NV - Product / Service
Exhibits 154: QIAGEN NV - Key news
Exhibits 155: QIAGEN NV - Key offerings
Exhibits 156: Sarepta Therapeutics Inc - Overview
Exhibits 157: Sarepta Therapeutics Inc - Product / Service
Exhibits 158: Sarepta Therapeutics Inc - Key offerings
Exhibits 159: System Biosciences LLC - Overview
Exhibits 160: System Biosciences LLC - Product / Service
Exhibits 161: System Biosciences LLC - Key offerings
Exhibits 162: Thermo Fisher Scientific Inc. - Overview
Exhibits 163: Thermo Fisher Scientific Inc. - Business segments
Exhibits 164: Thermo Fisher Scientific Inc. - Key news
Exhibits 165: Thermo Fisher Scientific Inc. - Key offerings
Exhibits 166: Thermo Fisher Scientific Inc. - Segment focus
Exhibits 167: Inclusions checklist
Exhibits 168: Exclusions checklist
Exhibits 169: Currency conversion rates for US$
Exhibits 170: Research methodology
Exhibits 171: Validation techniques employed for market sizing
Exhibits 172: Information sources
Exhibits 173: List of abbreviations

Executive Summary

The publisher recognizes the following companies as the key players in the global exosome diagnostics and therapeutics market: Aethlon Medical Inc., Bio Techne Corp., BioCat GmbH, BioVision Inc., Capricor Therapeutics Inc., Cell Guidance Systems Ltd., Clara Biotech Inc., Evox Therapeutics Ltd., Hologic Inc., JSR Life Sciences LLC, Lonza Group Ltd., Merck KGaA, Miltenyi Biotec B.V. and Co. KG, Nanosomix Inc., NX PharmaGen Inc., QIAGEN NV, ReNeuron Group plc, Sarepta Therapeutics Inc, System Biosciences LLC, and Thermo Fisher Scientific Inc..

Commenting on the report, an analyst from the research team said: 'The latest trend gaining momentum in the market is advanced technology in exosome collection.'

According to the report, one of the major drivers for this market is the rising research on exosome therapeutics.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.

Companies Mentioned

A selection of companies mentioned in this report includes:

  • Aethlon Medical Inc.
  • Bio Techne Corp.
  • BioCat GmbH
  • BioVision Inc.
  • Capricor Therapeutics Inc.
  • Cell Guidance Systems Ltd.
  • Clara Biotech Inc.
  • Evox Therapeutics Ltd.
  • Hologic Inc.
  • JSR Life Sciences LLC
  • Lonza Group Ltd.
  • Merck KGaA
  • Miltenyi Biotec B.V. and Co. KG
  • Nanosomix Inc.
  • NX PharmaGen Inc.
  • QIAGEN NV
  • ReNeuron Group plc
  • Sarepta Therapeutics Inc
  • System Biosciences LLC
  • Thermo Fisher Scientific Inc.